SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-163398
Filing Date
2024-06-18
Accepted
2024-06-18 16:07:31
Documents
21
Period of Report
2024-06-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d852840d8k.htm   iXBRL 8-K 42585
2 EX-4.1 d852840dex41.htm EX-4.1 85223
3 EX-4.2 d852840dex42.htm EX-4.2 87935
4 EX-5.1 d852840dex51.htm EX-5.1 25980
5 EX-10.1 d852840dex101.htm EX-10.1 120293
6 EX-10.2 d852840dex102.htm EX-10.2 138763
7 EX-10.3 d852840dex103.htm EX-10.3 17891
8 EX-10.4 d852840dex104.htm EX-10.4 12890
9 EX-99.1 d852840dex991.htm EX-99.1 11634
  Complete submission text file 0001193125-24-163398.txt   817829

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA asmb-20240616.xsd EX-101.SCH 2863
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE asmb-20240616_lab.xml EX-101.LAB 17995
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asmb-20240616_pre.xml EX-101.PRE 11270
24 EXTRACTED XBRL INSTANCE DOCUMENT d852840d8k_htm.xml XML 3638
Mailing Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 241051748
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)